$SSOK
Sunstock, Inc.

2024 Q2 Form 10-K Financial Statement

#000149315224012940 Filed on April 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $3.007M $2.896M $12.40M
YoY Change -4.8% -9.69% -4.74%
Cost Of Revenue $2.813M $2.653M $12.04M
YoY Change -9.96% -14.49% -5.44%
Gross Profit $193.7K $243.1K $355.3K
YoY Change 466.6% 132.53% 27.62%
Gross Profit Margin 6.44% 8.39% 2.87%
Selling, General & Admin $54.17K $22.36K $120.0K
YoY Change 167.77% 53.15% 5.12%
% of Gross Profit 27.96% 9.2% 33.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $55.00 $50.00 $220.00
YoY Change 0.0% 0.0% -74.45%
% of Gross Profit 0.03% 0.02% 0.06%
Operating Expenses $61.45K $30.23K $151.3K
YoY Change 115.89% 25.07% 0.81%
Operating Profit $132.3K $212.8K $204.0K
YoY Change 2209.22% 164.85% 58.95%
Interest Expense $129.2K $59.35K $5.710K
YoY Change -402.93% -54.66% -1.07%
% of Operating Profit 97.65% 27.89% 2.8%
Other Income/Expense, Net $129.2K -$117.9K
YoY Change -177.7% -96.88%
Pretax Income $261.4K $272.2K $8.290K
YoY Change -262.88% -107.56% -100.23%
Income Tax $2.400K $2.400K
% Of Pretax Income 0.88% 28.95%
Net Earnings $261.4K $269.8K $5.890K
YoY Change -262.88% -107.49% -100.16%
Net Earnings / Revenue 8.7% 9.32% 0.05%
Basic Earnings Per Share $0.05 $0.00
Diluted Earnings Per Share $0.05 $0.05 $0.00
COMMON SHARES
Basic Shares Outstanding 5.022M shares 5.022M shares 4.925M shares
Diluted Shares Outstanding 5.022M shares 4.925M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.680K $13.79K $13.79K
YoY Change -42.51% -17.38% -17.38%
Cash & Equivalents $5.682K $13.79K
Short-Term Investments
Other Short-Term Assets $21.01K $9.330K $9.330K
YoY Change 18.37% 80.81% 80.81%
Inventory $2.457M $2.088M $2.088M
Prepaid Expenses $21.01K $9.327K
Receivables
Other Receivables
Total Short-Term Assets $2.484M $2.111M $2.111M
YoY Change 36.06% 19.01% 19.01%
LONG-TERM ASSETS
Property, Plant & Equipment $92.00 $37.32K $37.32K
YoY Change -70.61% 8701.89% 223.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $28.65K $37.32K $37.32K
YoY Change 805.63% 223.45% 223.68%
TOTAL ASSETS
Total Short-Term Assets $2.484M $2.111M $2.111M
Total Long-Term Assets $28.65K $37.32K $37.32K
Total Assets $2.513M $2.148M $2.148M
YoY Change 37.39% 20.33% 20.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $584.4K $544.8K $544.8K
YoY Change 29.78% 19.76% 19.76%
Deferred Revenue
YoY Change
Short-Term Debt $99.24K $25.68K $25.68K
YoY Change 328.0% 328.0%
Long-Term Debt Due $2.570K $8.370K $8.370K
YoY Change -61.58% 65.74% 65.74%
Total Short-Term Liabilities $722.5K $615.2K $615.2K
YoY Change 46.47% 22.48% 22.48%
LONG-TERM LIABILITIES
Long-Term Debt $147.2K $141.6K $141.6K
YoY Change 2.72% -2.29% -2.29%
Other Long-Term Liabilities $9.880K $20.89K $20.89K
YoY Change
Total Long-Term Liabilities $157.1K $162.5K $162.5K
YoY Change 9.62% 12.12% 12.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $722.5K $615.2K $615.2K
Total Long-Term Liabilities $157.1K $162.5K $162.5K
Total Liabilities $879.6K $777.7K $777.7K
YoY Change 38.17% 20.16% 20.16%
SHAREHOLDERS EQUITY
Retained Earnings -$65.65M -$65.91M
YoY Change -0.67% -0.01%
Common Stock $502.00 $502.00
YoY Change 0.0% 4.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.633M $1.370M $1.370M
YoY Change
Total Liabilities & Shareholders Equity $2.513M $2.148M $2.148M
YoY Change 37.39% 20.33% 20.33%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $261.4K $269.8K $5.890K
YoY Change -262.88% -107.49% -100.16%
Depreciation, Depletion And Amortization $55.00 $50.00 $220.00
YoY Change 0.0% 0.0% -74.45%
Cash From Operating Activities -$25.95K -$17.76K -$120.1K
YoY Change -12.74% -74.05% -56.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.86K 13.47K 117.2K
YoY Change -26.07% -74.1% -54.88%
NET CHANGE
Cash From Operating Activities -25.95K -17.76K -120.1K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 25.86K 13.47K 117.2K
Net Change In Cash -90.00 -4.290K -2.900K
YoY Change -101.72% -73.92% -78.48%
FREE CASH FLOW
Cash From Operating Activities -$25.95K -$17.76K -$120.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001559157
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022 SSOK Lawsuit Judgement
LawsuitJudgement
usd
CY2023 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
usd
CY2022Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
usd
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
usd
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Security12b Title
Security12bTitle
Common Stock.
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1346340 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5021857 shares
CY2023 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13790 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16691 usd
CY2023Q4 SSOK Inventory Coins Current
InventoryCoinsCurrent
1272999 usd
CY2022Q4 SSOK Inventory Coins Current
InventoryCoinsCurrent
950637 usd
CY2023Q4 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
814574 usd
CY2022Q4 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
801022 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9327 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5155 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2110690 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1773505 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37120 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11114 usd
CY2023Q4 us-gaap Assets
Assets
2148013 usd
CY2022Q4 us-gaap Assets
Assets
1785043 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
564933 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11114 usd
CY2023Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
8368 usd
CY2022Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
5047 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
16233 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
615215 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
502298 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
141632 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
144953 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
20887 usd
CY2023Q4 us-gaap Liabilities
Liabilities
777734 usd
CY2022Q4 us-gaap Liabilities
Liabilities
647251 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5021857 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5021857 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4815857 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4815857 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
502 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
481 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67279869 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67053289 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65910092 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65915978 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1370279 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2148013 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1785043 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12397189 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13013682 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
12041893 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
12735272 usd
CY2023 us-gaap Gross Profit
GrossProfit
355296 usd
CY2022 us-gaap Gross Profit
GrossProfit
278410 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
820 usd
CY2023 SSOK Lawsuit Judgement
LawsuitJudgement
77863 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
229121 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
150043 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
126175 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
128367 usd
CY2022 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
56709 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13553 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
21445 usd
CY2023 us-gaap Interest Expense
InterestExpense
5772 usd
CY2022 us-gaap Interest Expense
InterestExpense
5772 usd
CY2023 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
123600 usd
CY2022 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
3867927 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-117889 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8286 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3651033 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
5886 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3651833 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4924783 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4924783 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4209501 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4209501 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
514911 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4274714 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3651833 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
226601 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
5886 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
5886 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1370279 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1370279 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
5886 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3651833 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13553 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
21445 usd
CY2023 us-gaap Depreciation
Depreciation
221 usd
CY2022 us-gaap Depreciation
Depreciation
861 usd
CY2023 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
123600 usd
CY2022 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
3867927 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
CY2022 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
56709 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
322362 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
280839 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4172 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-500 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90318 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-101376 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-120062 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-273164 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
117161 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
259687 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117161 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
259687 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2901 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13477 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16691 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30168 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13790 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16691 usd
CY2023 us-gaap Stock Issued1
StockIssued1
103000 usd
CY2022 us-gaap Stock Issued1
StockIssued1
3106120 usd
CY2022 SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
30250 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_z8lHxTiXN457" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zRVlHa6Sebt8">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zB3rNGAOs8O4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zqBhozJl9qKf">CONCENTRATION OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13553 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
21445 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65910092 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58257 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58036 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
221 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
861 usd
CY2023Q4 SSOK Lawsuit Judgment
LawsuitJudgment
338171 usd
CY2022Q4 SSOK Lawsuit Judgment
LawsuitJudgment
260308 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133649 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
131500 usd
CY2023Q4 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
12726 usd
CY2022Q4 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
16176 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
20208 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14436 usd
CY2023Q4 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
14934 usd
CY2022Q4 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
8089 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4631 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8919 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8671 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
564933 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
23095 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8940 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8940 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8940 usd
CY2023Q4 SSOK Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
200405 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
250320 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
100320 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
150000 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
8368 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
141632 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P26Y4M24D
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
800 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2400 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
800 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210000 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.358959 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.000277 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000000 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.000000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.000000 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3.666457 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.210000 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-3.097498 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000277 pure
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1736000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1770000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
14698000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
14698000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16434000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16468000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16434000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16468000 usd

Files In Submission

Name View Source Status
0001493152-24-012940-index-headers.html Edgar Link pending
0001493152-24-012940-index.html Edgar Link pending
0001493152-24-012940.txt Edgar Link pending
0001493152-24-012940-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_004.jpg Edgar Link pending
form10-k_005.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssok-20231231.xsd Edgar Link pending
ssok-20231231_def.xml Edgar Link unprocessable
ssok-20231231_lab.xml Edgar Link unprocessable
ssok-20231231_pre.xml Edgar Link unprocessable
ssok-20231231_cal.xml Edgar Link unprocessable